3-10101265-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000421731.5(FANCD2):n.*515C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.377 in 1,598,442 control chromosomes in the GnomAD database, including 122,502 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.30 ( 8908 hom., cov: 30)
Exomes 𝑓: 0.38 ( 113594 hom. )
Consequence
FANCD2
ENST00000421731.5 non_coding_transcript_exon
ENST00000421731.5 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.25
Publications
35 publications found
Genes affected
FANCD2 (HGNC:3585): (FA complementation group D2) The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group D2. This protein is monoubiquinated in response to DNA damage, resulting in its localization to nuclear foci with other proteins (BRCA1 AND BRCA2) involved in homology-directed DNA repair. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 3-10101265-C-T is Benign according to our data. Variant chr3-10101265-C-T is described in ClinVar as Benign. ClinVar VariationId is 257063.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.419 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FANCD2 | NM_001018115.3 | c.*3C>T | 3_prime_UTR_variant | Exon 44 of 44 | ENST00000675286.1 | NP_001018125.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FANCD2 | ENST00000675286.1 | c.*3C>T | 3_prime_UTR_variant | Exon 44 of 44 | NM_001018115.3 | ENSP00000502379.1 |
Frequencies
GnomAD3 genomes AF: 0.305 AC: 46212AN: 151522Hom.: 8908 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
46212
AN:
151522
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.330 AC: 82734AN: 250506 AF XY: 0.339 show subpopulations
GnomAD2 exomes
AF:
AC:
82734
AN:
250506
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.385 AC: 556520AN: 1446806Hom.: 113594 Cov.: 29 AF XY: 0.383 AC XY: 276099AN XY: 720590 show subpopulations
GnomAD4 exome
AF:
AC:
556520
AN:
1446806
Hom.:
Cov.:
29
AF XY:
AC XY:
276099
AN XY:
720590
show subpopulations
African (AFR)
AF:
AC:
2323
AN:
33364
American (AMR)
AF:
AC:
9711
AN:
44676
Ashkenazi Jewish (ASJ)
AF:
AC:
12382
AN:
26032
East Asian (EAS)
AF:
AC:
5784
AN:
39640
South Asian (SAS)
AF:
AC:
20129
AN:
85978
European-Finnish (FIN)
AF:
AC:
24558
AN:
53320
Middle Eastern (MID)
AF:
AC:
2337
AN:
5746
European-Non Finnish (NFE)
AF:
AC:
457330
AN:
1098142
Other (OTH)
AF:
AC:
21966
AN:
59908
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
15177
30354
45530
60707
75884
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
13542
27084
40626
54168
67710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.305 AC: 46215AN: 151636Hom.: 8908 Cov.: 30 AF XY: 0.305 AC XY: 22586AN XY: 74090 show subpopulations
GnomAD4 genome
AF:
AC:
46215
AN:
151636
Hom.:
Cov.:
30
AF XY:
AC XY:
22586
AN XY:
74090
show subpopulations
African (AFR)
AF:
AC:
3422
AN:
41344
American (AMR)
AF:
AC:
4422
AN:
15220
Ashkenazi Jewish (ASJ)
AF:
AC:
1656
AN:
3470
East Asian (EAS)
AF:
AC:
712
AN:
5164
South Asian (SAS)
AF:
AC:
1117
AN:
4810
European-Finnish (FIN)
AF:
AC:
4937
AN:
10464
Middle Eastern (MID)
AF:
AC:
135
AN:
294
European-Non Finnish (NFE)
AF:
AC:
28690
AN:
67862
Other (OTH)
AF:
AC:
697
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1432
2864
4295
5727
7159
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
452
904
1356
1808
2260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
723
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jan 10, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.